daunorubicin has been researched along with Cancer of Ovary in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (28.79) | 18.7374 |
1990's | 24 (36.36) | 18.2507 |
2000's | 9 (13.64) | 29.6817 |
2010's | 11 (16.67) | 24.3611 |
2020's | 3 (4.55) | 2.80 |
Authors | Studies |
---|---|
Gennari, C; Halmos, G; Juhász, É; Mező, G; Neundorf, I; Schuster, S | 1 |
Wang, H; Wang, X; Yang, D; Zhang, R | 1 |
Birault, A; Doan, TLH; Intasa-Ard, SG; Mai, NXD; Matsumoto, K; Morrison, K; Ta, HKT; Tamanoi, F; Thang, PB | 1 |
Bukowska, B; Denel, M; Gajek, A; Marczak, A; Rogalska, A | 1 |
Bukowska, B; Marczak, A; Rogalska, A | 3 |
Bukowska, B; Denel-Bobrowska, M; Gajek, A; Marczak, A; Maszewski, J; Rogalska, A | 1 |
Brys, M; Bukowska, B; Forma, E; Marczak, A; Rogalska, A | 1 |
Narayanan, G; Soman, LV | 1 |
Chen, ML; Chen, XH; Shaw, AB; Volpe, DA; Zhou, L | 1 |
Fodor, Z; Galuska, L; Goda, K; Hernádi, Z; Krasznai, ZT; Mikecz, P; Szabó, G; Tóth, A | 1 |
Edwards, K; Fondell, A; Gedda, L; Kullberg, E; Park, JW; Unga, J | 1 |
Gajek, A; Jóźwiak, Z; Marczak, A; Rogalska, A; Szwed, M | 1 |
Chorvath, B; Duraj, J; Hunakova, L; Jakubikova, J; Sedlak, J | 1 |
Coleman, A; Kane, SE; Sadava, D | 1 |
Assaraf, YG; Hooijberg, JH; Jansen, G; Kaspers, GJ; Kathmann, I; Laan, AC; Peters, GJ; Pieters, R; Veerman, AJ | 1 |
Bennett, CL; Calhoun, EA | 1 |
Breitbach, K; Jekerle, V; Klinkhammer, W; Piquette-Miller, M; Reilly, RM; Scollard, DA; Wiese, M | 1 |
Gayer, B; Hodge, RP; Kalchenko, V; Katzburg, S; Kohen, F; Meshorer, A; Nevo, N; Renevey, MD; Somjen, D; Stern, N | 1 |
Crespeigne, N; Decoster, G; Kenis, Y; Klastersky, J; Rombaut, W; Rozencweig, M; Sanders, C | 1 |
Myers, CE; Ozols, RF; Young, RC | 1 |
Chu, TM; Kawinski, E; Lin, TH | 1 |
Bogush, T; Robert, J; Shubina, I; Smirnova, G; Syrkin, A | 1 |
Chorváth, B; Hrubisko, M; Hunáková, L; McGown, A; Sedlák, J | 1 |
Dekker, H; Lankelma, J; Pinedo, HM; Spoelstra, EC; Westerhoff, HV | 1 |
Guiral, M; Lankelma, J; Viratelle, O; Westerhoff, HV | 1 |
Chorváth, B; Novotný, L; Sedlák, J | 1 |
Belliot, SO; Crommelin, DJ; Haisma, HJ; Smit, RH; Storm, G; Vingerhoeds, MH | 1 |
de Vries, EG; Elsinga, PH; Fluks, L; Franssen, EJ; Hendrikse, NH; Vaalburg, W; van der Graaf, WT; Visser, GM; Weemaes, AM | 1 |
Animati, F; Arcamone, F; Bigioni, M; Capranico, G; Caserini, C; De Cesare, M; Lombardi, P; Pratesi, G; Salvatore, C; Supino, R; Zunino, F | 1 |
Dyson, PG; Juttner, CA; Roberts, MM; To, LB; Willson, K | 1 |
Bast, A; Boven, E; de Jong, J; Kuiper, CM; van der Vijgh, WJ | 1 |
Boezeman, J; de Witte, T; Pennings, A; Raymakers, R; Smeets, M; van de Locht, L; Vierwinden, G; Wessels, H | 1 |
De Bruijn, EA; Elst, HE; Gheuens, EE; van der Heyden, SA; Van Oosterom, AT | 1 |
Coley, HM; Sargent, JM; Taylor, C; Williamson, C | 1 |
Lang, J; Shen, K; Zhu, L | 1 |
Boven, E; Erkelens, CA; Haisma, HJ; Houba, PH; Leenders, RG; Pinedo, HM; Scheeren, JW | 1 |
Boven, E; Haisma, HJ; Houba, PH; Leenders, RG; Pinedo, HM; Scheeren, JW; van der Meulen-Muileman, IH | 1 |
Fujii, S; Fukushi, Y; Futagami, M; Higuchi, T; Saito, Y; Sakamoto, T; Sato, S; Takami, H; Yokoyama, Y | 1 |
Chithrathara, K; Elizabath, KA; Gangadharan, VP; Preetha, S; Sreejith, G | 1 |
Muggia, FM | 1 |
Hinderer, H; Kaufmann, M; Mattern, J; Volm, M; Wayss, K | 1 |
Gol'dberg, LE | 1 |
Burchenal, J; D'angio, G; Exelby, P; Fang, S; Lieberman, P; Murphy, ML; Wollner, N | 1 |
Kaufmann, M; Mattern, J; Volm, M; Wayss, K | 1 |
Broxterman, HJ; Dekker, H; Lankelma, J; Schuurhuis, GJ; Spoelstra, EC | 1 |
De Bruijn, EA; Gheuens, EE; Tanke, HJ; van Bockstaele, DR; van der Keur, M; van Oosterom, AT | 1 |
Kraayenhof, R; Lankelma, J; Mülder, HS; van Grondelle, R; van Mourik, F; Wong Fong Sang, HW | 1 |
Broxterman, HJ; Dekker, H; Lankelma, J; Spoelstra, EC | 1 |
Crowther, D; Fox, BW; McGown, AT; Murphy, D | 1 |
Dezsö, B; Rosik, LO; Sweet, F; Török, I | 1 |
Broxterman, HJ; Lankelma, J; Pinedo, HM; Schuurhuis, GJ | 1 |
Cavalli, F; Kaye, SB; Renard, J; Sessa, C; ten Bokkel Huinink, W | 1 |
Collins, JL; Rosik, LO; Sommers, GM; Sweet, F | 1 |
Broxterman, HJ; Kuiper, CM; Lankelma, J; Pinedo, HM; Schuurhuis, GJ; Tsuruo, T | 1 |
Dodion, P; Kenis, Y; Kitt, MM; Klastersky, J; Rombaut, W; Rozencweig, M; Sanders, C | 1 |
Broxterman, HJ; Kaptein, LC; Kuiper, CM; Lankelma, J; Pinedo, HM; Schuurhuis, GJ | 1 |
Copeland, LJ; Edwards, CL; Gershenson, DM; Kavanagh, JJ; Saul, PB | 1 |
Broxterman, HJ; Kuiper, CM; Lankelma, J; Pinedo, HM; Schuurhuis, GJ; van der Hoeven, JJ | 1 |
Bruzzone, M; Chiara, S; Conte, PF; Falcone, A; Graziani, G; Rosso, R | 1 |
Daghestani, AN; Dougherty, JB; Hakes, TB; Raymond, V; Weiselberg, L | 1 |
Lazo, JS; Schwartz, PE | 1 |
Mattern, J; Volm, M; Wayss, K | 1 |
Frei, E; Lokich, JJ; Skarin, AT | 1 |
Hawk, IA; Levy, CC; Russell, DH; Schimpff, SC | 1 |
5 review(s) available for daunorubicin and Cancer of Ovary
Article | Year |
---|---|
New potential chemotherapy for ovarian cancer - Combined therapy with WP 631 and epothilone B.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Epothilones; Female; Humans; Ovarian Neoplasms | 2016 |
Pharmacoeconomics of liposomal anthracycline therapy.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Costs and Cost Analysis; Daunorubicin; Doxorubicin; Female; Humans; Liposomes; Male; Multiple Myeloma; Ovarian Neoplasms; Sarcoma, Kaposi | 2004 |
The anthracycline antineoplastic drugs.
Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Daunorubicin; Doxorubicin; Female; Glycosides; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Naphthacenes; Ovarian Neoplasms; Sarcoma | 1981 |
Liposomal encapsulated anthracyclines: new therapeutic horizons.
Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Breast Neoplasms; Daunorubicin; Doxorubicin; Female; Humans; Leukemia; Liposomes; Lymphoma; Multiple Myeloma; Ovarian Neoplasms; Sarcoma, Kaposi | 2001 |
[Antibacterial and antineoplastic antibiotics].
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bacteria; Bacterial Infections; Chemical Phenomena; Chemistry; Choriocarcinoma; Daunorubicin; Erythromycin Ethylsuccinate; Female; Hodgkin Disease; Humans; Leukemia; Lincomycin; Lymphoma, Large B-Cell, Diffuse; Olivomycins; Ovarian Neoplasms; Pregnancy; Ristocetin; Streptonigrin; Uterine Neoplasms | 1977 |
1 trial(s) available for daunorubicin and Cancer of Ovary
Article | Year |
---|---|
Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Bone Marrow; Cell Differentiation; Cell Lineage; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Megakaryocytes; Multiple Myeloma; Ovarian Neoplasms; Platelet Count; Thioguanine; Time Factors | 1996 |
60 other study(ies) available for daunorubicin and Cancer of Ovary
Article | Year |
---|---|
Development and Biochemical Characterization of Self-Immolative Linker Containing GnRH-III-Drug Conjugates.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cathepsin B; Cell Line, Tumor; Daunorubicin; Female; Gonadotropin-Releasing Hormone; Humans; Molecular Targeted Therapy; Ovarian Neoplasms; Paclitaxel; Petromyzon; Pyrrolidonecarboxylic Acid; Receptors, LHRH | 2022 |
Discrimination of Multidrug Resistance in Cancer Cells Achieved Using Single-Cell Analysis.
Topics: Biological Transport; Coloring Agents; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Female; Humans; Ovarian Neoplasms; Single-Cell Analysis | 2023 |
Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle-Based Anticancer Drug.
Topics: Animals; Antibiotics, Antineoplastic; Cell Proliferation; Chickens; Daunorubicin; Drug Carriers; Drug Delivery Systems; Female; Humans; Nanoparticles; Neoplasms, Experimental; Organosilicon Compounds; Ovarian Neoplasms; Particle Size; Porosity; Surface Properties; Tumor Cells, Cultured | 2020 |
Pro-apoptotic activity of new analog of anthracyclines--WP 631 in advanced ovarian cancer cell line.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Calcium; Caspases; Cell Line, Tumor; Cell Survival; Comet Assay; Cytochromes c; Daunorubicin; DNA Damage; Doxorubicin; Female; Humans; Membrane Potential, Mitochondrial; Ovarian Neoplasms; Phosphatidylserines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species | 2014 |
WP 631 and Epo B synergize in SKOV-3 human ovarian cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Daunorubicin; Drug Synergism; Epothilones; Female; Humans; Ovarian Neoplasms | 2014 |
Caspases and ROS - dependent mechanism of action mediated by combination of WP 631 and epothilone B.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Daunorubicin; DNA Damage; DNA Repair; Drug Synergism; Epothilones; Female; Humans; Membrane Potential, Mitochondrial; Ovarian Neoplasms; Reactive Oxygen Species | 2014 |
Early Activation of Apoptosis and Caspase-independent Cell Death Plays an Important Role in Mediating the Cytotoxic and Genotoxic Effects of WP 631 in Ovarian Cancer Cells.
Topics: Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Calcium; Caspases; Comet Assay; Cytochromes c; Daunorubicin; DNA Damage; Female; Flow Cytometry; Histones; Humans; Ovarian Neoplasms; Phosphorylation; Tumor Cells, Cultured | 2015 |
Why a Combination of WP 631 and Epo B is an Improvement on the Drugs Singly - Involvement in the Cell Cycle and Mitotic Slippage.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Proteins; Daunorubicin; Drug Synergism; Drug Therapy, Combination; Epothilones; Female; Humans; Mitosis; Ovarian Neoplasms; Real-Time Polymerase Chain Reaction; Tumor Cells, Cultured | 2016 |
Lymphoblastic Lymphoma Presenting as Bilateral Ovarian Mass in an Adolescent Girl.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Daunorubicin; Diagnosis, Differential; Female; Humans; Lymphoma, B-Cell; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Vincristine | 2017 |
Effect of altered temperature storage on the in vitro cellular uptake of liposome drug products.
Topics: Animals; Cell Line; Daunorubicin; Doxorubicin; Female; Humans; Liposomes; Macrophages; Mice; Ovarian Neoplasms; Temperature | 2010 |
Pgp inhibition by UIC2 antibody can be followed in vitro by using tumor-diagnostic radiotracers, 99mTc-MIBI and 18FDG.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Daunorubicin; Drug Resistance, Multiple; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ovarian Neoplasms; Paclitaxel; Protein Binding; Rhodamine 123; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 2010 |
In vitro evaluation and biodistribution of HER2-targeted liposomes loaded with an (125)I-labelled DNA-intercalator.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Humans; Injections, Intraperitoneal; Intercalating Agents; Iodine Radioisotopes; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Receptor, ErbB-2; Tissue Distribution | 2011 |
The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.
Topics: Acetylcysteine; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Membrane Potential, Mitochondrial; Ovarian Neoplasms; Reactive Oxygen Species | 2011 |
PK11195, an isoquinoline carboxamide ligand of the mitochondrial benzodiazepine receptor, increased drug uptake and facilitated drug-induced apoptosis in human multidrug-resistant leukemia cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carcinoma; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluoresceins; Fluorescent Dyes; HL-60 Cells; Humans; Isoquinolines; Leukemia, Myeloid; Ligands; Mitochondrial Proteins; Ovarian Neoplasms; Receptors, GABA-A; Tumor Cells, Cultured | 2002 |
Liposomal daunorubicin overcomes drug resistance in human breast, ovarian and lung carcinoma cells.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma, Small Cell; Cell Death; Daunorubicin; Drug Resistance, Neoplasm; Female; Humans; Inhibitory Concentration 50; Liposomes; Lung Neoplasms; Ovarian Neoplasms; Tumor Cells, Cultured | 2002 |
Folate concentration dependent transport activity of the Multidrug Resistance Protein 1 (ABCC1).
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Daunorubicin; Female; Folic Acid; Folic Acid Deficiency; Gene Expression; Humans; Nucleotides; Ovarian Neoplasms; Time Factors; Tumor Cells, Cultured | 2004 |
In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
Topics: Antineoplastic Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Cell Line, Tumor; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorescence; Gene Expression Regulation, Neoplastic; Humans; Mitoxantrone; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Time Factors; Tissue Distribution; Transplantation, Heterologous; Up-Regulation | 2006 |
A daidzein-daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Daunorubicin; Female; Humans; Isoflavones; Mice; Mice, Nude; Molecular Structure; Ovarian Neoplasms; Phytoestrogens; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Phase II study of carminomycin in a human tumor cloning assay.
Topics: Breast Neoplasms; Carubicin; Colony-Forming Units Assay; Daunorubicin; Doxorubicin; Drug Evaluation; Female; Humans; Melanoma; Ovarian Neoplasms; Tumor Stem Cell Assay | 1984 |
Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antibody Specificity; Antigens, Neoplasm; Antigens, Surface; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carrier Proteins; CHO Cells; Cricetinae; Daunorubicin; Doxorubicin; Drug Resistance; Epitopes; Female; Humans; KB Cells; Membrane Glycoproteins; Neoplasm Proteins; Ovarian Neoplasms; Protein Structure, Tertiary; Tumor Cells, Cultured; Vincristine | 1993 |
Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines.
Topics: Animals; Binding Sites; Bisbenzimidazole; Carcinoma; Cell Division; Cyanoacrylates; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Female; Glioblastoma; Humans; Leukemia, Erythroblastic, Acute; Ovarian Neoplasms; Polyglutamic Acid; Polymers; Rats; Tumor Cells, Cultured | 1995 |
Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line.
Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antigens, Surface; Cell Cycle; Daunorubicin; DNA, Neoplasm; Drug Resistance; Female; Humans; Ovarian Neoplasms; Tumor Cells, Cultured | 1994 |
The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Culture Media; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Kinetics; Lung Neoplasms; Membrane Glycoproteins; Models, Biological; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil | 1994 |
Cooperative P-glycoprotein mediated daunorubicin transport into DNA-loaded plasma membrane vesicles.
Topics: Adenosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Carrier Proteins; Cell Membrane; Daunorubicin; DNA; Drug Resistance; Female; Humans; Kinetics; Liposomes; Magnesium; Membrane Glycoproteins; Ovarian Neoplasms; Spectrometry, Fluorescence; Tumor Cells, Cultured; Verapamil | 1994 |
The protein kinase C inhibitor, CGP 41 251, reverses decreased daunomycin uptake in a human drug-resistant ovarian carcinoma cell line.
Topics: Alkaloids; Daunorubicin; Drug Resistance; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Protein Kinase C; Staurosporine; Tumor Cells, Cultured | 1994 |
Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Binding Sites; Carcinoma; Cross-Linking Reagents; Daunorubicin; Drug Carriers; Female; Glucuronates; Glucuronidase; Humans; Imidoesters; Immunoglobulin Fab Fragments; Liposomes; Mice; Ovarian Neoplasms; Prodrugs; Succinimides; Sulfides; Tumor Cells, Cultured | 1996 |
Carbon-11-labeled daunorubicin and verapamil for probing P-glycoprotein in tumors with PET.
Topics: Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbon Radioisotopes; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Male; Ovarian Neoplasms; Rats; Rats, Wistar; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured; Verapamil | 1996 |
Biochemical and pharmacological activity of novel 8-fluoroanthracyclines: influence of stereochemistry and conformation.
Topics: Animals; Anthracyclines; Antibiotics, Antineoplastic; Cell Line; Cell Survival; Daunorubicin; DNA Topoisomerases, Type II; Doxorubicin; Female; Fluorine; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Models, Molecular; Molecular Conformation; Molecular Structure; Ovarian Neoplasms; Stereoisomerism; Structure-Activity Relationship; Transplantation, Heterologous; Tumor Cells, Cultured | 1996 |
Relationship between the tumour tissue pharmacokinetics and the antiproliferative effects of anthracyclines and their metabolites.
Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 1996 |
A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicity.
Topics: Antigens, CD34; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Southern; Cell Division; Daunorubicin; Doxorubicin; Female; Hematopoietic Stem Cells; Humans; Immunohistochemistry; Ovarian Neoplasms; Rhodamines; Tumor Cells, Cultured; Verapamil | 1997 |
Comparison of daunorubicin and Fluo-3 for detection of multidrug resistance in human tumor cells.
Topics: Aniline Compounds; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Fluorescent Dyes; Humans; Ovarian Neoplasms; Tumor Cells, Cultured; Xanthenes | 1997 |
Evidence of ABC transporters in fresh tumor cells from patients with ovarian cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporins; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Immunohistochemistry; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Ovarian Neoplasms; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles | 1998 |
[The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cyclosporine; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Genes, MDR; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Random Allocation; Tumor Cells, Cultured; Vincristine | 1997 |
The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts.
Topics: Animals; Cell Division; Daunorubicin; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Ovarian Neoplasms; Prodrugs; Transplantation, Heterologous | 1998 |
Distribution and pharmacokinetics of the prodrug daunorubicin-GA3 in nude mice bearing human ovarian cancer xenografts.
Topics: Animals; Area Under Curve; Daunorubicin; Female; Glucuronidase; Humans; Injections, Intravenous; Mice; Mice, Nude; Neoplasm Transplantation; Ovarian Neoplasms; Prodrugs; Tissue Distribution; Transplantation, Heterologous | 1999 |
Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Liver Neoplasms; Middle Aged; Mitoxantrone; Ovarian Neoplasms; Prednisolone; Remission Induction; Reoperation | 2000 |
Primary granulocytic sarcoma of the ovary.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid; Ovarian Neoplasms; Remission Induction | 2000 |
Sensitivity tests of tumors to cytostatic agents. II. Investigation on human tumors.
Topics: Antineoplastic Agents; Autoradiography; Breast Neoplasms; Cell Count; Cell Division; Culture Techniques; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Neoplasms; Nucleic Acids; Ovarian Neoplasms; Procarbazine; Uridine | 1975 |
Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Lymph Nodes; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Skin Neoplasms; Stomach Neoplasms; Thioguanine; Vincristine | 1975 |
[Testing of the resistance of human tumours in the short-term test (author's transl)].
Topics: Antibiotics, Antineoplastic; Dactinomycin; Daunorubicin; Doxorubicin; Drug Resistance; Female; Humans; Lung Neoplasms; Ovarian Neoplasms; Thymidine; Triaziquone; Uridine | 1975 |
P-glycoprotein drug efflux pump involved in the mechanisms of intrinsic drug resistance in various colon cancer cell lines. Evidence for a saturation of active daunorubicin transport.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Survival; Colonic Neoplasms; Daunorubicin; Drug Resistance; Female; Glycerol; Humans; Membrane Glycoproteins; Mice; Neoplasm Proteins; Ovarian Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Verapamil | 1991 |
Flow cytometric double labeling technique for screening of multidrug resistance.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Transformed; Daunorubicin; Drug Resistance; Female; Flow Cytometry; Fluorescent Dyes; Humans; Membrane Glycoproteins; Ovarian Neoplasms | 1991 |
Cellular daunomycin fluorescence in multidrug resistant 2780AD cells and its relation to cellular drug localisation.
Topics: Daunorubicin; DNA, Neoplasm; Drug Resistance; Female; Fluorescence Polarization; Humans; Intercalating Agents; Models, Biological; Ovarian Neoplasms; Tumor Cells, Cultured | 1991 |
Evidence for daunomycin efflux from multidrug-resistant 2780AD human ovarian carcinoma cells against a concentration gradient.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Daunorubicin; Drug Resistance; Female; Humans; Membrane Glycoproteins; Ovarian Neoplasms; Tumor Cells, Cultured; Verapamil | 1990 |
Effect of verapamil on daunorubicin accumulation in lymphocytes isolated from patients undergoing chemotherapy.
Topics: Daunorubicin; Epithelium; Female; Humans; Lymphocytes; Ovarian Neoplasms; Time Factors; Verapamil | 1991 |
Human ovarian cancers specifically bind daunorubicin-OC-125 conjugate: an immunofluorescence study.
Topics: Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Cystadenocarcinoma; Daunorubicin; Drug Carriers; Female; Fluorescent Antibody Technique; Humans; Immunotoxins; Ovarian Neoplasms | 1990 |
Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Cell Line; Cyclosporins; Daunorubicin; Drug Resistance; Energy Metabolism; Female; Humans; Lactates; Lactic Acid; Ovarian Neoplasms; Verapamil | 1990 |
Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
Topics: Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Menogaril; Middle Aged; Nogalamycin; Ovarian Neoplasms | 1989 |
Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells.
Topics: Adenocarcinoma; Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Daunorubicin; Female; Humans; Immunotoxins; Lethal Dose 50; Ovarian Neoplasms; Tumor Cells, Cultured | 1989 |
Increase of daunorubicin and vincristine accumulation in multidrug resistant human ovarian carcinoma cells by a monoclonal antibody reacting with P-glycoprotein.
Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Daunorubicin; Drug Resistance; Female; Humans; Membrane Glycoproteins; Ovarian Neoplasms; Tumor Cells, Cultured; Vincristine | 1988 |
In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assay.
Topics: Breast Neoplasms; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Female; Humans; Menogaril; Neoplastic Stem Cells; Nogalamycin; Ovarian Neoplasms; Tumor Stem Cell Assay | 1986 |
Induction by verapamil of a rapid increase in ATP consumption in multidrug-resistant tumor cells.
Topics: Adenosine Triphosphate; Animals; Daunorubicin; Drug Resistance; Female; Humans; Hydrolysis; Osmolar Concentration; Ovarian Neoplasms; Phenotype; Tumor Cells, Cultured; Verapamil; Vincristine | 1988 |
A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer.
Topics: Adult; Aged; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Idarubicin; Leukocyte Count; Middle Aged; Ovarian Neoplasms | 1986 |
Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein binding.
Topics: Antibiotics, Antineoplastic; Calcium Channel Blockers; Cell Line; Daunorubicin; Drug Resistance; Female; Humans; Naphthacenes; Ovarian Neoplasms; Protein Binding | 1987 |
4-Demethoxydaunorubicin (IMI-30) in refractory epithelial ovarian cancer: a pilot study.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma; Daunorubicin; Drug Resistance; Female; Humans; Idarubicin; Middle Aged; Ovarian Neoplasms | 1987 |
Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Granulosa Cell Tumor; Humans; Idarubicin; Middle Aged; Ovarian Neoplasms | 1985 |
Rapid distribution of adriamycin in the ascitic and pleural fluid of women with ovarian carcinomas.
Topics: Ascitic Fluid; Chromatography, High Pressure Liquid; Cystadenocarcinoma; Daunorubicin; Doxorubicin; Female; Humans; Kinetics; Middle Aged; Naphthacenes; Ovarian Neoplasms; Pleural Effusion; Reference Standards | 1985 |
[The effects of cytostatic agents on short-term cultures (3H-uridine incorporation) and tissue cultures (cell counts) from human tumors (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Cell Count; Cell Transformation, Neoplastic; Cells, Cultured; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Drug Evaluation, Preclinical; Female; Fluorouracil; Humans; In Vitro Techniques; Methods; Methotrexate; Neoplasms; Ovarian Neoplasms; Podophyllin; Suspensions; Time Factors; Triaziquone; Tritium; Uridine | 1974 |
1,-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (methyl CCNU) and adriamycin combination therapy.
Topics: Adult; Aged; Alopecia; Breast Neoplasms; Cyclohexanes; Daunorubicin; Digestive System; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Heart; Humans; Kidney Neoplasms; Leukopenia; Male; Middle Aged; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Parotid Neoplasms; Stomatitis; Thrombocytopenia; Vision Disorders | 1974 |
Urinary polyamines in cancer patients.
Topics: Brain Neoplasms; Chemistry, Clinical; Daunorubicin; Female; Hodgkin Disease; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Neoplasms; Ovarian Neoplasms; Polyamines; Pregnancy; Remission, Spontaneous; Spermidine; Spermine; Teratoma | 1971 |